Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-30

Clinical Trial Update: Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating topical NAVS Naphthalan for oral mucosal diseases (Oral Lichen Planus and Recurrent aphthous stomatitis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAVS Naphthalan (Non-Aromatic Very Rich in Steranes)

Snippet

Sponsor: Ivan Alajbeg | Conditions: Oral Lichen Planus, Recurrent Aphthous Stomatitis | Phase 2 | Status: COMPLETED